43
Growth Score in past quarter
pts
Heat Score 43 in past quarter
-28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1353027
Dahlman Lab specializes in genetic therapy research, focusing on lipid nanoparticles and extracellular vesicles.
About the Company
Dahlman Lab combines omics, nanotechnology, and drug delivery research to develop RNA therapeutics and scalable nanoparticle formulations. It focuses on creating DNA‑barcoded lipid nanoparticles that can be screened in vivo to evaluate hundreds of delivery vehicles simultaneously. The lab applies these tools to design systems able to target tissues
beyond the liver, including lung, heart, and stem cell populations, and to deliver multi‑gene payloads such as siRNA, mRNA, or Cas9. It collaborates with industry and supports translational work that advances novel therapies toward clinical use.